Stockscreener 앱 받기
0.3788
3.54%
-0.0139
시간 외 거래:
.36
-0.0188
-4.96%
전일 마감가:
$0.3927
열려 있는:
$0.3928
하루 거래량:
14.80M
Relative Volume:
1.60
시가총액:
$19.07M
수익:
-
순이익/손실:
$-11.53M
주가수익비율:
-0.0786
EPS:
-4.82
순현금흐름:
$-11.12M
1주 성능:
+77.67%
1개월 성능:
+97.70%
6개월 성능:
+45.69%
1년 성능:
-69.94%
1일 변동 폭
$0.3171
$0.438
1주일 범위
$0.2076
$0.5697
52주 변동 폭
$0.15
$1.50
프로세사 파마슈티컬스 Stock (PCSA) Company Profile
명칭
Processa Pharmaceuticals Inc
전화
443-776-3133
주소
601 21ST STREET, SUITE 300, VERO BEACH
PCSA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PCSA
Processa Pharmaceuticals Inc
|
0.3788 | 21.92M | 0 | -11.53M | -11.12M | -4.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
프로세사 파마슈티컬스 Stock (PCSA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-04-25 | 개시 | H.C. Wainwright | Buy |
프로세사 파마슈티컬스 주식(PCSA)의 최신 뉴스
Using AI based signals to follow Processa Pharmaceuticals Inc.Market Weekly Review & Momentum Based Trading Ideas - newser.com
Can swing trading help recover from Processa Pharmaceuticals Inc. lossesJuly 2025 Volume & Free Technical Confirmation Trade Alerts - newser.com
Live market analysis of Processa Pharmaceuticals Inc.Trade Performance Summary & AI Forecast for Swing Trade Picks - newser.com
Forecasting Processa Pharmaceuticals Inc. price range with options dataWeekly Profit Analysis & Weekly High Momentum Picks - newser.com
Top chart patterns to watch in Processa Pharmaceuticals Inc.2025 Year in Review & Risk Managed Investment Entry Signals - newser.com
Is Processa Pharmaceuticals Inc. stock a buy before product launches2025 Momentum Check & Safe Capital Preservation Plans - newser.com
Using economic indicators to assess Processa Pharmaceuticals Inc. potentialQuarterly Profit Summary & Weekly Watchlist of Top Performers - newser.com
Is Processa Pharmaceuticals Inc. still worth holding after the dipQuarterly Market Summary & Stepwise Entry and Exit Trade Signals - newser.com
Is Processa Pharmaceuticals Inc. stock a defensive play in 2025July 2025 Spike Watch & Capital Protection Trading Alerts - newser.com
How Processa Pharmaceuticals Inc. stock reacts to inflationary pressures2025 Momentum Check & Free Expert Verified Stock Movement Alerts - newser.com
Why Processa Pharmaceuticals Stock Rose Almost 38% Overnight? - Benzinga
Biotech Stocks Surge After Hours: PCSA, PALI, And QTTB Lead On Volume And Speculation - Nasdaq
TELO, PCSA, RVPH, NMTC, BRTX Jump In After-Hours Trading On Light News Flow And Select Updates - RTTNews
Momentum divergence signals in Processa Pharmaceuticals Inc. chart2025 Trading Volume Trends & High Accuracy Swing Entry Alerts - newser.com
Published on: 2025-10-05 04:03:55 - newser.com
Can machine learning forecast Processa Pharmaceuticals Inc. recovery2025 Market Sentiment & Free Reliable Trade Execution Plans - newser.com
Published on: 2025-10-03 04:24:10 - newser.com
Published on: 2025-10-03 02:09:35 - newser.com
Processa Pharmaceuticals' chief business officer buys $34,691 in stock - MSN
Ulcerated Necrobiosis Lipoidica Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Observes | Processa Pharmaceuticals - The Globe and Mail
Strategies to average down on Processa Pharmaceuticals Inc.Quarterly Trade Review & Daily Growth Stock Investment Tips - newser.com
Published on: 2025-09-29 04:18:13 - newser.com
Published on: 2025-09-29 03:25:55 - newser.com
What analysts say about Processa Pharmaceuticals Inc stockVolume Analysis Techniques & Minimal Investment Trading - earlytimes.in
What drives Processa Pharmaceuticals Inc stock priceStock Correlation Metrics & Exceptional Profit Growth Tips - earlytimes.in
프로세사 파마슈티컬스 (PCSA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
프로세사 파마슈티컬스 주식 (PCSA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Ng George K | Chief Executive Officer |
Jan 27 '25 |
Buy |
0.80 |
87,200 |
69,542 |
87,200 |
| Young David | Pres. Research & Development |
Jan 27 '25 |
Buy |
0.80 |
124,500 |
99,289 |
205,405 |
| Lin Patrick | Chief Business - Strategy Off |
Jan 27 '25 |
Buy |
0.80 |
43,500 |
34,691 |
43,500 |
5.74%
자본화:
|
볼륨(24시간):